(Q64129035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Japanese encephalitis

1 reference

1 reference

M B Bista

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M K Banerjee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S H Shin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J B Tandan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M H Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Y M Sohn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

H C Ohrr

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J L Tang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S B Halstead

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

9284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

791-795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

The epidemiology of Japanese encephalitis: prospects for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Protection against Japanese encephalitis by inactivated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Use of the case-control approach in vaccine evaluation: efficacy and adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

Exact inference for matched case-control studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

The exposure odds ratio in nested case-control studies with competing risks.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905967-0

7 January 2021

10.1016/S0140-6736(01)05967-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564484%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference